# Alzheimer's Drug Discovery Foundation (ADDF) > The Alzheimer's Drug Discovery Foundation (ADDF) is a private non-profit organization dedicated purely to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. Using a venture philanthropy model, it funds high-risk, high-reward scientific research that often falls into the 'valley of death' between academic discovery and pharmaceutical development. - URL: https://optimly.ai/brand/alzheimer-s-drug-discovery-foundation-addf - Slug: alzheimer-s-drug-discovery-foundation-addf - BAI Score: 84/100 - Archetype: Challenger - Category: Non-profit Organization - Last Analyzed: April 9, 2026 ## Competitors - Alzheimers Association (https://optimly.ai/brand/alzheimers-association) - Alzheimers Disease Data Initiative Addi (https://optimly.ai/brand/alzheimers-disease-data-initiative-addi) - Alzheimers Research Uk (https://optimly.ai/brand/alzheimers-research-uk) ## Buyer Intent Signals Problems: Internal Philanthropic Management: Conducting small-scale fundraisers or family offices managing their own philanthropic venture portfolios without specialized scientific vetting. | General Health Foundations: Donating to broad health charities that cover multiple diseases rather than focusing purely on Alzheimer's therapeutics. Solutions: venture philanthropy for Alzheimer's | who funds alzheimer's drug discovery | best organizations for alzheimer's research donations | Alzheimer's Diagnostics Accelerator | how to get alzheimer's patient care support | Government Grants (NIH): Relying on government-funded research grants from the NIH/NIA which are often slower and more risk-averse.